Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacokinetic and antidrug antibody status of ABP-959 biosimilar compared to eculizumab

Dec. 17, 2019

Sanofi presents data from phase I repeat-dosing study of BIVV-001

Dec. 17, 2019

First patient enrolled in pivotal phase III InnovAATe study of Kamada's inhaled AAT

Dec. 17, 2019

Health Canada approves Erleada for the treatment of mCSPC

Dec. 17, 2019

FDA removes partial clinical hold for multiple-ascending-dose study of RGLS-4326

Dec. 17, 2019

BioMarin reports encouraging final phase III data for vosoritide in children with achondroplasia

Dec. 17, 2019

BARDA exercises option to support Qpex product development

Dec. 17, 2019

Allopregnanolone affects metabolic and lipid pathways in Alzheimer's disease

Dec. 17, 2019

OAT-1746, a novel arginase inhibitor, reduces tumor growth in murine glioma models

Dec. 17, 2019

Soricimed provides update on its PDC program, including in vivo data for SBI-1301

Dec. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...